Relay Therapeutics Inc
RLAY · NASDAQ
Relay Therapeutics, Inc. operates as a biotechnology company. The Company develops durgs for the treatment of cancer. Relay Therapeutics serves customers in the United States.
Market Data
Price
$15.20
+0.39 (+2.63%)
Market Cap$3.23B
P/E Ratio—
EPS$—
52W High$17.47
52W Low$2.98
Beta1.70
Data from Finnhub · Updated Jun 15, 2026